{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:03:54Z","timestamp":1790129034840,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013130","name":"Military Traumatic Brain Injury Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009898","name":"Defense Health Agency Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e00975","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:29:25Z","timestamp":1784755765000},"page":"e00975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease-modifying effects on chronic axon damage and white matter degeneration with 4-aminopyridine after acute traumatic brain injury"],"prefix":"10.1016","volume":"23","author":[{"given":"Kryslaine L.","family":"Radomski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina C.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neurot.2026.e00975_bib1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","article-title":"Traumatic brain injury: progress and challenges in prevention, clinical care, and research","volume":"21","author":"Maas","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2026.e00975_bib2","series-title":"Proceedings of a Workshop of the national academies of sciences, engineering, and medicine","article-title":"Examining traumatic brain injury as a chronic condition","author":"Yost","year":"2026"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib3","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/HTR.0000000000000975","article-title":"Summary of the centers for disease control and prevention's self-reported traumatic brain injury survey efforts","volume":"40","author":"Daugherty","year":"2025","journal-title":"J Head Trauma Rehabil"},{"issue":"613","key":"10.1016\/j.neurot.2026.e00975_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg9922","article-title":"Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury","volume":"13","author":"Graham","year":"2021","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00975_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.tins.2024.07.003","article-title":"White matter damage and degeneration in traumatic brain injury","volume":"47","author":"Armstrong","year":"2024","journal-title":"Trends Neurosci"},{"issue":"13-14","key":"10.1016\/j.neurot.2026.e00975_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/neu.2024.0581","volume":"42","author":"Bazarian","year":"2025","journal-title":"J Neurotrauma"},{"issue":"5-6","key":"10.1016\/j.neurot.2026.e00975_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/neu.2021.0348","article-title":"Symptom frequency and persistence in the first year after traumatic brain injury: a TRACK-TBI study","volume":"39","author":"Machamer","year":"2022","journal-title":"J Neurotrauma"},{"issue":"9665","key":"10.1016\/j.neurot.2026.e00975_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","article-title":"Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial","volume":"373","author":"Goodman","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00975_bib9","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000976","article-title":"Neuroprotective properties of 4-Aminopyridine","volume":"8","author":"Dietrich","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40478-022-01366-z","article-title":"Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury","volume":"10","author":"Radomski","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-025-02219-1","article-title":"Mapping the secondary response to traumatic brain injury using spatial transcriptomics shows acute 4-aminopyridine treatment mitigates axonal and molecular pathology","volume":"24","author":"Sullivan","year":"2026","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00975_bib12","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1212\/WNL.0000000000007970","article-title":"Effect of dalfampridine on information processing speed impairment in multiple sclerosis","volume":"93","author":"De Giglio","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00975_bib13","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41380-024-02820-1","article-title":"The effect of fampridine on working memory: a randomized controlled trial based on a genome-guided repurposing approach","volume":"30","author":"Papassotiropoulos","year":"2025","journal-title":"Mol Psychiatr"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00975_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/neu.2012.2825","article-title":"Therapy development for diffuse axonal injury","volume":"30","author":"Smith","year":"2013","journal-title":"J Neurotrauma"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00975_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/NEN.0000000000000165","article-title":"Components of myelin damage and repair in the progression of white matter pathology after mild traumatic brain injury","volume":"74","author":"Mierzwa","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"41","key":"10.1016\/j.neurot.2026.e00975_bib16","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1523\/JNEUROSCI.0819-18.2018","article-title":"Experimental traumatic brain injury identifies distinct early and late phase axonal conduction deficits of white matter pathophysiology, and reveals intervening recovery","volume":"38","author":"Marion","year":"2018","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40478-021-01193-8","article-title":"Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures","volume":"9","author":"Bradshaw","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00975_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/NEN.0000000000000009","article-title":"Oligodendrocyte lineage and subventricular zone response to traumatic axonal injury in the corpus callosum","volume":"72","author":"Sullivan","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurot.2026.e00975_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.expneurol.2012.01.013","article-title":"Axonal pathology in traumatic brain injury","volume":"246","author":"Johnson","year":"2013","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00975_bib20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00401-022-02498-1","article-title":"Concussion leads to widespread axonal sodium channel loss and disruption of the node of Ranvier","volume":"144","author":"Song","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00975_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.70090","article-title":"Evolution of axonal injury in the closed head impact model of engineered rotational acceleration in adult ferrets","volume":"103","author":"Krieg","year":"2025","journal-title":"J Neurosci Res"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00975_bib22","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"issue":"22","key":"10.1016\/j.neurot.2026.e00975_bib23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1089\/neu.2014.3861","article-title":"Pre-clinical traumatic brain injury common data elements: toward a common language across laboratories","volume":"32","author":"Smith","year":"2015","journal-title":"J Neurotrauma"},{"issue":"9-10","key":"10.1016\/j.neurot.2026.e00975_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/neu.2023.0653","article-title":"Prospective harmonization, common data elements, and sharing strategies for multicenter pre-clinical traumatic brain injury research in the translational outcomes project in neurotrauma consortium","volume":"42","author":"Wanner","year":"2025","journal-title":"J Neurotrauma"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-025-02219-1","article-title":"Mapping the secondary response to traumatic brain injury using spatial transcriptomics shows acute 4-aminopyridine treatment mitigates axonal and molecular pathology","volume":"14","author":"Sullivan","year":"2026","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00975_bib26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.clinthera.2012.03.007","article-title":"The safety profile of dalfampridine extended release in multiple sclerosis clinical trials","volume":"34","author":"Cornblath","year":"2012","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00975_bib27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14740338.2012.697896","article-title":"Clinical overview of the seizure risk of dalfampridine","volume":"11","author":"Haut","year":"2012","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0920-1211(92)90016-M","article-title":"Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice","volume":"11","author":"Yamaguchi","year":"1992","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neurot.2026.e00975_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115360","article-title":"Serum evaluation of NFL correlates with histological identification of degenerating axons","volume":"392","author":"Fusco","year":"2025","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00975_bib30","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1212\/WNL.0000000000009983","article-title":"Neurofilament light as a biomarker in traumatic brain injury","volume":"95","author":"Shahim","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00975_bib31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-023-02622-9","article-title":"Neuronal tau pathology worsens late-phase white matter degeneration after traumatic brain injury in transgenic mice","volume":"146","author":"Yu","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"Pt 1","key":"10.1016\/j.neurot.2026.e00975_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/aws322","article-title":"Inflammation and white matter degeneration persist for years after a single traumatic brain injury","volume":"136","author":"Johnson","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00975_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI196638","article-title":"Early axonal degeneration linked to clinical decline in Alzheimer's disease progression revealed with diffusion MRI","volume":"136","author":"Gong","year":"2026","journal-title":"J Clin Investig"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00975_bib34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneurol.2012.200","article-title":"Neuroprotection and repair in multiple sclerosis","volume":"8","author":"Franklin","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00975_bib35","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/epi.13582","article-title":"Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a Traumatic Brain injury model systems study","volume":"57","author":"Ritter","year":"2016","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00975_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/1759091414551782","article-title":"Comparison of cortical and white matter traumatic brain injury models reveals differential effects in the subventricular zone and divergent sonic hedgehog signaling pathways in neuroblasts and oligodendrocyte progenitors","volume":"6","author":"Mierzwa","year":"2014","journal-title":"ASN Neuro"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13023-021-01694-8","article-title":"Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials","volume":"16","author":"Zhang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurot.2026.e00975_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113040","article-title":"Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury","volume":"321","author":"Marion","year":"2019","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00975_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1474-4422(25)00154-1","article-title":"A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI classification and nomenclature initiative","volume":"24","author":"Manley","year":"2025","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00975_bib40","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/brain\/awae075","article-title":"Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration","volume":"147","author":"Ding","year":"2024","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00975_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s13311-022-01198-8","article-title":"Inhibition of transient receptor potential Vanilloid 4 (TRPV4) mitigates seizures","volume":"19","author":"Zeng","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"45","key":"10.1016\/j.neurot.2026.e00975_bib42","doi-asserted-by":"crossref","first-page":"11652","DOI":"10.1523\/JNEUROSCI.2490-06.2006","article-title":"Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia","volume":"26","author":"Franciosi","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2026.e00975_bib43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2023.02.066","article-title":"Potassium channels at the crossroads of neuroinflammation and myelination in experimental models of multiple sclerosis","volume":"653","author":"I","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00975_bib44","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awaa062","article-title":"Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis","volume":"143","author":"Dietrich","year":"2020","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00975_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/NEN.0b013e31820937e4","article-title":"Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging","volume":"70","author":"Tobin","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"43","key":"10.1016\/j.neurot.2026.e00975_bib46","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1523\/JNEUROSCI.0604-20.2020","article-title":"The integrated UPR and ERAD in oligodendrocytes maintain myelin thickness in adults by regulating myelin protein translation","volume":"40","author":"Wu","year":"2020","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.neurot.2026.e00975_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41582-022-00737-3","article-title":"Adaptive and maladaptive myelination in health and disease","volume":"18","author":"Knowles","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41598-017-18747-3","article-title":"Development of a PET radioligand for potassium channels to image CNS demyelination","volume":"8","author":"Brugarolas","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e00975_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1627517","article-title":"Potassium channel clustering: mechanisms shaping axonal excitability","volume":"19","author":"Escobedo","year":"2025","journal-title":"Front Cell Neurosci"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00975_bib50","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1909-23.2025","article-title":"Downmodulation of potassium conductances induces epileptic seizures in cortical network models via multiple synergistic factors","volume":"45","author":"Ho \u4f55\u93ae\u5b87","year":"2025","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41583-025-00986-3","article-title":"Programmed axon degeneration: mechanism, inhibition and therapeutic potential","volume":"27","author":"Loreto","year":"2026","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib52","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1038\/s41598-025-24517-3","article-title":"Combinatorial chemistry identifies additional compounds that selectively inhibit DLK-dependent retrograde signaling while minimally affecting other axonal roles of DLK","volume":"16","author":"Zhang","year":"2026","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00975_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2528118123","article-title":"Caspase-3 cleaves and activates the NADase SARM1 to promote apoptosis, linking two cell death mechanisms","volume":"123","author":"Shi","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00975_bib54","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s13311-023-01427-8","article-title":"Application of P7C3 compounds to investigating and treating acute and chronic traumatic brain injury","volume":"20","author":"Sridharan","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00975_bib55","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41467-025-56292-0","article-title":"The transcriptional response of cortical neurons to concussion reveals divergent fates after injury","volume":"16","author":"Alkaslasi","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2026.e00975_bib56","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1089\/neu.2016.4569","article-title":"Repetitive model of mild traumatic brain injury produces cortical abnormalities detectable by magnetic resonance diffusion imaging (DTI\/DKI), histopathology, and behavior","volume":"34","author":"Yu","year":"2017","journal-title":"J Neurotrauma"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:08:16Z","timestamp":1790125696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926001455"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00975","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-modifying effects on chronic axon damage and white matter degeneration with 4-aminopyridine after acute traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00975"}}